(Q52195491)

26 April 2018

meta-analysis

0 references

title

Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated. (English)

1 reference

26 April 2018

author name string

Weiner I

1

1 reference

26 April 2018

Tarrasch R

2

1 reference

26 April 2018

Bernasconi E

3

1 reference

26 April 2018

Broersen LM

4

1 reference

26 April 2018

Rüttimann TC

5

1 reference

26 April 2018

Feldon J

6

1 reference

26 April 2018

language of work or name

English

0 references

publication date

1 April 1997

1 reference

26 April 2018

Pharmacology, Biochemistry and Behavior

published in

1 reference

26 April 2018

volume

56

1 reference

26 April 2018

page(s)

817-826

1 reference

26 April 2018

issue

4

1 reference

26 April 2018

The disorder of consciousness in schizophrenia.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Haloperidol enhancement of latent inhibition: Relation to therapeutic action?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Consciousness, Information Processing and Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Effect of intracaudate haloperidol and apomorphine on switching motor patterns upon current behaviour of cats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Latent inhibition in humans: data, theory, and implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

A theory of attention: Variations in the associability of stimuli with reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

The role of noradrenaline in tuning and dopamine in switching between signals in the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

The case of frontostriatal dysfunction in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Functional studies of the central catecholamines.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

1 reference

7 January 2021

The involvement of the nucleus accumbens in the ability of rats to switch to cue-directed behaviours

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Neural substrates of latent inhibition: the switching model

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Disruption of latent inhibition by acute administration of low doses of amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2896%2900417-0

7 January 2021

10.1016/S0091-3057(96)00417-0

Identifiers

DOI

1 reference

26 April 2018

PubMed ID

9130310

1 reference

26 April 2018